DIAGNOSTIC AND PROGNOSTIC VALUE OF FLOW CYTOMETRIC DETECTION OF LYMPHOBLASTS IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO HAVE UNDETECTABLE BLASTS BY CSF CYTOLOGY.

EHA Library, Kavya Keerthana, 419825

THE FIRST RESULTS OF THE RALL-2016M PROTOCOL: “MRD-STATUS” BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS

EHA Library, Olga Aleshina Gavrilina, 419826

IMPROVING OUTCOME IN ELDERLY PHILADELPHIA NEGATIVE ACUTE LIMPHOBLASTIC LEUKEMIA: FEASIBILITY AND EFFICACY OF AN INTENSIVE PEG-ASPARAGINASE-BASED REGIMEN

EHA Library, Maria Chies, 419827

USE OF GLUCARPIDASE IN PAEDIATRIC CANCER PATIENTS: 12 YEARS OF EXPERIENCE.

EHA Library, Alba Rubio-San-Simón, 419828

DISTINCTIVE SPATIOTEMPORAL CLUSTERING PATTERNS OF ACUTE LEUKEMIA AND TYPE 1 DIABETES IN FINLAND

EHA Library, Julia Ventelä, 419829

BLINATUMOMAB'S EFFECTIVENESS AND SAFETY IN ADOLESCENTS AND YOUNG ADULTS(AYA) PATIENTS WITH PHILADELPHIA-NEGATIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA(ALL) AFTER INITIAL THERAPY: SINGLE-CENTER STUDY

EHA Library, Ahmed Kotb Abdrabou, 419830

DNMT3A MUTATIONS IN PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WERE TREATED BY PROTOCOL RALL-2016

EHA Library, Anastasia Vasilieva, 419831

TRANSCRIPTOME SEQUENCING-BASED SUBTYPING IMPROVES RISK STRATIFICATION IN PEDIATRIC B-ALL PATIENTS: A STUDY FROM INDIA

EHA Library, Anita Chopra, 419832

EXPERIENCE WITH BLINATUMOMAB IN ADULTS WITH ACUTE B LYMPHOBLASTIC LEUKEMIA IN LATIN AMERICA: MULTICENTER RETROSPECTIVE STUDY

EHA Library, Victor Urbalejo, 419833

CENTRE EFFECT ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A REGISTRY-BASED STUDY IN JAPAN

EHA Library, Shuhei Kurosawa, 419834

SOMATIC MUTATIONS IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Maria Agustina Perusini, 419835

EFFICACY AND SAFETY OF MITOXANTRONE HYDROCHLORIDE LIPOSOME COMBINED WITH CLAG REGIMEN IN REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA (NON-M3)

EHA Library, Kai Wan, 419836

THE EFFICACY AND SAFETY OF SHORTEN PERIOD OF BINATUMOMAB AND SEQUENTIAL ALLO-HSCT IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Hai Yi, 419837

SAFETY AND EFFICACY OF BLINATUMOMAB AS BRIDGING THERAPY IN PEDIATRIC B-ALL PATIENTS WITH CHEMOTHERAPY INTOLERANCE: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Xiuli Ju, 419838

CYCLOPENTA[B]INDOLES: NOVEL ANTIMICROTUBULE AGENTS EXHIBITING ANTILEUKEMIA ACTIVITY

EHA Library, Hugo Passos Vicari, 419839

STAT3 IN ACUTE MYELOID LEUKEMIA FACILITATES NATURAL KILLER CELL-MEDIATED SURVEILLANCE

EHA Library, Agnieszka Witalisz-Siepracka, 419840

ΓΔ T CELLS IMPROVE THE FUNCTIONAL IMPAIRMENT OF ΑΒ T CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Keli Yue, 419841

IN SILICO ANALYSIS OF DDX41 INHIBITORS BINDING MECHANISMS

EHA Library, Davide Crucitti, 419842

TUSPETINIB RETAINS NANOMOLAR POTENCY AGAINST AML CELLS ENGINEERED TO EXPRESS THE NRASG12D MUTATION OR SELECTED FOR RESISTANCE TO VENETOCLAX

EHA Library, Stephen Howell MD, 419843

THE IMPACT OF PD-1 AND PD-L1 EXPRESSION ON TREATMENT OUTCOMES IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Uğur Çalış, 419845

NEUROPEPTIDE TIP39 INDUCES AUTOPHAGY IN PTH2 RECEPTOR-POSITIVE MYELOID NEOPLASMS.

EHA Library, Hiroto Horiguchi, 419846

ERRΑ INHIBITION: PRECISION TREATMENT FOR AML PATIENTS

EHA Library, wonhyoung Seo, 419847

HIGH-SENSITIVITY AUTOMATIZED FLOW CYTOMETRY STRATEGY FOR THE STUDY OF MEASURABLE RESIDUAL DISEASE IN AML. COMPLEMENTARY ROLE OF THE NEXT GENERATION SEQUENCING.

EHA Library, Paula Piñero, 419848

DNA BASE EDITING TO MODEL HOT SPOT MUTATIONS AND RECONSTRUCT MYELOID DISEASE DEVELOPMENT

EHA Library, Johannes Foßelteder, 419849

COMBINATION OF SELINEXOR WITH PI3K/MTOR DUAL INHIBITOR OMIPALISIB EXHIBITS SYNERGISTIC EFFECTS IN ACUTE MYELOID CELLS WITH DIFFERENT GENETIC BACKGROUND IN VITRO AND IN VIVO

EHA Library, Liang-In Lin, 419850

SLIT2 DEFICIENCY IS ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES AND INCREASED STEM-CELL SUPPORT BY MESENCHYMAL STEM CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Luise A de A Simoes, 419851

WTAP UPREGULATES PHF19 EXPRESSION THROUGH RNA METHYLATION (M6A) MODIFICATION TO PROMOTE T (8;21) ACUTE MYELOID LEUKEMIA CELL PROLIFERATION

EHA Library, yuqing li, 419852

PLINABULIN AND SELUMETINIB TREATMENT INCREASES M1-RELATED FEATURES IN MACROPHAGES

EHA Library, Lucio Henrique Sousa Pinheiro, 419853

ADVANTAGES AND PROGNOSTIC VALUE OF NEXT GENERATION SEQUENCING-BASED MUTANT NPM1 MEASURABLE RESIDUAL DISEASE DETECTION IN AML

EHA Library, Christian Vonk, 419854

DIGITAL CYTOGENOMICS IMPROVES CLINICAL DIAGNOSTICS OF ACUTE MYELOID LEUKEMIA

EHA Library, Anna Bekő, 419855

MESENCHYMAL STROMAL CELLS PROTECT ACUTE MYELOID LEUKAEMIA CELLS FROM VENETOCLAX-INDUCED APOPTOSIS THROUGH A CD90-MEDIATED ADHESION PATHWAY

EHA Library, Marilena Ciciarello, 419856

ANTILEUKEMIC ACTIVITY OF CD33-DIRECTED MUTATION-AGNOSTIC LINTUZUMAB-AC225 IN KMT2A MUTANT AML

EHA Library, Helen Kotanides, 419857

THE NOVEL COMBINATION OF QUINACRINE AND VALPROIC ACID FOR TREATMENT OF ACUTE MYELOID LEUKEMIA

EHA Library, Oriol CASTELLS, 419858

DIFFERENTIAL RESPONSE TO ATR/CHK1 INHIBITION IN PRELEUKEMIA AND TRANSFORMED LEUKEMIA IN AN MLL-ENL MODEL OF LEUKEMOGENESIS

EHA Library, Pavla Chaloupkova, 419859

EPIGENETIC REGULATION OF CD52 IN ACUTE MYELOID LEUKEMIA AND ITS POTENTIAL CONNECTION WITH THE AKT SIGNALING PATHWAY

EHA Library, Carlos Quero-Dotor, 419860

THE HOXA9/DNA BINDING INHIBITORS: IMPACT ON GENE REGULATION OF DB1055 AND DB818 RELATIVELY TO HOXA9 KNOCKDOWN.

EHA Library, Marie-Helene David-Cordonnier, 419861

DECIPHERING EARLY STEPS OF TP53 ABERRANT HUMAN LEUKEMOGENESIS

EHA Library, Karin Lind, 419862

DEVELOPMENT OF A CUSTOM NGS PANEL FOR MEASURABLE RESIDUAL DISEASE ASSESMENT IN ACUTE MYELOID LEUKEMIA

EHA Library, Guillermo Ramil, 419863

GERMLINE VARIANT DISCOVERY AND PATHOGENICITY EVALUATION IN HEMATOLOGICAL DISEASES HIGHLIGHTS THE ROLE OF CHEK2 VARIANTS

EHA Library, Outi Kilpivaara, 419864

COMPUTATIONAL MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA USING MIXTURE MODELS

EHA Library, Tim Mocking, 419865

CEPHALOCHROMIN-INDUCED MITOCHONDRIAL METABOLISM DOWNREGULATION OVERCOMES VENETOCLAX RESISTANCE IN DIVERSE ACUTE MYELOID LEUKEMIA MODELS

EHA Library, Mariane Cristina Do Nascimento, 419866

CEBPA ISOFORMS DIFFERENTIALLY CONTROL INFLAMMATORY TRANSCRIPTIONAL PROGRAMS

EHA Library, Maria Cadefau, 419867

GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY IN MAINLY ASIAN PATIENTS WITH RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: REGIONAL SUB-ANALYSIS OF COMMODORE IN CHINA, SOUTH-EAST ASIA, RUSSIA

EHA Library, Jianxiang Wang, 419868

VENETOCLAX COMBINED WITH FLAG-IDA (FLAVIDA) IN REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA (R/R-AML)

EHA Library, Kai Wille, 419869

MULTICENTRE REAL-WORLD OUTCOMES FOR PATIENTS TREATED WITH VENETOCLAX AND AZACITIDINE FOR ACUTE MYELOID LEUKAEMIA IN THE NORTH OF ENGLAND

EHA Library, Nuno Borges, 419870

CLINICAL CHARACTERISTICS OF ACUTE LEUKEMIA WITH PICALM::MLLT10 FUSION IN ADULTS

EHA Library, Sankalp Arora, 419871

MYELOID NEOPLASMS IN OVARIAN CANCER PATIENTS TREATED WITH PARP INHIBITORS: REAL-LIFE EXPERIENCE FROM AN ONCOLOGY CENTER.

EHA Library, Rosario Custidiano, 419872

PREGNANCY OUTCOMES IN PATIENTS WITH ACUTE LEUKEMIA DIAGNOSED AT DIFFERENT GESTATION AGES: A MORE THAN 30 YEARS NATIONAL RESEARCH GROUP FOR THE TREATMENT OF ACUTE LEUKEMIA EXPERIENCE.

EHA Library, Vera Troitskaya, 419873

INCIDENCE AND OUTCOME OF ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22.2) – A DANISH NATIONWIDE POPULATION-BASED RETROSPECTIVE COHORT STUDY

EHA Library, Johannes Frasez Sørensen, 419874

TREATMENT PATTERNS AND OUTCOMES OF VENETOCLAX+HYPOMETHYLATING AGENTS VS HYPOMETHYLATING MONOTHERAPY IN PATIENTS ENROLLED IN MEDICARE ADVANTAGE WITH ACUTE MYELOID LEUKEMIA UNFIT FOR INTENSIVE THERAPY

EHA Library, Catherine Lai, 419875

IMPACT OF MALNUTRITION ON SURVIVAL AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC NEOPLASM: A COMPREHENSIVE ANALYSIS

EHA Library, Daniel Cabello Modesto, 419876

SAFETY OUTCOMES IN ADULT PATIENTS WITH AML WHO ACHIEVED THEIR FIRST COMPLETE REMISSION WITH GO PRIOR TO HSCT

EHA Library, Nelli Bejanyan, 419877

REAL-WORLD OVERALL SURVIVAL, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE USE AMONG NEWLY DIAGNOSED UNFIT MEDICARE BENEFICIARIES WITH ACUTE MYELOID LEUKEMIA

EHA Library, Amer M. Zeidan, 419878

TIME TO HEMATOLOGIC RECOVERY IS A CRITICAL DETERMINANT OF COMPLETE REMISSION AS A SURROGATE FOR OVERALL SURVIVAL AFTER INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Rithin Nedumannil, 419879

A PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE FOR PATIENTS WITH NEWLY DIAGNOSED CD123-POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Naval Daver, 419881

SELINEXOR COMBINATION WITH DECITABINE AND HALF-DOSE CMG (CYTARABINE+ MITOXANTRONE+G-CSF) IN PATIENTS WITH R/R AML PREVIOUSLY EXPOSED TO VENETOCLAX：A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Zi-Yuan Nie, 419882

OUTCOMES WITH IMMUNE-BASED THERAPIES FOR TP53 MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Moazzam Shahzad, 419883

CLINICAL PHARMACOLOGY AND PHARMACOKINETIC PROFILE OF ZIFTOMENIB, A MENIN INHIBITOR, IN ADULTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Amitava Mitra, 419884

CLINICAL OUTCOMES OF RELAPSED AND/OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH GILTERITINIB

EHA Library, Elizabeth Corley, 419885

SINGLE-CENTER EXPERIENCE OF DECITABINE AND VENETOCLAX IN NEWLY DIAGNOSED OLDER AML PATIENTS WITH NON-FAVORABLE GENETICS: BRIDGING TO ALLO-HCT OR TREATMENT CONTINUATION

EHA Library, David Alber, 419886

UPDATES FROM A SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA HYPOMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Xiao-Ning Gao, 419887

INCIDENCE, PROGNOSTIC IMPACT AND NGS-BASED MRD ASSESSMENT OF ASXL2 MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Henri C. Hupe, 419888

SELINEXOR AND CHIDAMIDE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA EXPOSED TO VENETOCLAX: A SINGLE-ARM, PHASE 2 STUDY

EHA Library, Jian Zhang, 419889

FLT3-ITD MICROCLONES ARE DETECTED AT RELAPSE IN PATIENTS WITH FLT3-ITD AML AFTER INTENSIVE CHEMOTHERAPY

EHA Library, Zhi Han Yeoh, 419890

REAL WORLD ANALYSIS OF CPX-351 VS 7+3 INDUCTION IN ACUTE MYELOID LEUKEMIA-MYELODYSPLASIA RELATED (AML-MR) IN PATIENTS (PTS) <60 YEARS (Y): AN ANALYSIS FROM MARROW CONSORTIUM

EHA Library, Daniel Peters, 419891

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES WITH ORAL AZACITIDINE MAINTENANCE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN CANADA

EHA Library, Brian Leber, 419892

TREATMENT PATTERNS AND MOLECULAR TESTING ACROSS THE PATIENT JOURNEY: A REAL-WORLD ANALYSIS IN A U.S.-BASED COHORT OF NEWLY DIAGNOSED AND RELAPSED/REFRACTORY AML PATIENTS

EHA Library, Amer M. Zeidan, 419893

THE PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF SOMATIC GENE MUTATIONS AMONG DE NOVO ACUTE MYELOID LEUKAEMIA PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

EHA Library, Shehab Fareed Abdelgabber, 419894

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION BRINGS SURVIVAL BENEFIT IN PATIENTS WITH ASXL1 MUTATED ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION

EHA Library, Mohamed Kawari, 419895

REAL-WORLD USE OF FIRST-LINE MIDOSTAURIN IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A MULTICENTRIC STUDY FROM THE GRUPO PORTUGUÊS DE LEUCEMIAS AGUDAS

EHA Library, Joana Infante, 419897

PATIENT CHARACTERISTICS, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION IN ACUTE MYELOID LEUKEMIA – AN ANALYSIS OF GERMAN CLAIMS DATA

EHA Library, Moritz Lehne, 419898

INTEGRATIVE ANALYSIS OF IMMUNE CHECKPOINT MOLECULES EXPRESSION DEFINES DISTINCT PROGNOSTIC CLUSTERS IN AML PATIENTS

EHA Library, Milan Jagurinoski, 419899

CONCOMITANT MUTATION OF DNA METHYLATION RELATED GENES PREDICTED A SUBTYPE OF ASXL1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Cai Yiming, 419900

MUTATIONS IN THE RUNX1 GENE IN AML PATIENTS.

EHA Library, Natali Severina, 419901

TREATMENT OUTCOMES FOR PATIENTS WITH BCOR-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Ryan Jackson, 419902

PATIENT-CENTERED GENOMIC DIAGNOSTIC TESTING FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA: A QUALITY IMPROVEMENT PROJECT

EHA Library, Jenny Ho, 419903

IRON-RELATED LABORATORY PROFILE MAY PREDICT SURVIVAL, RISK OF INFECTION AND TRANSFUSIONAL NEED IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE AND NON-INTENSIVE THERAPY REGIMENS

EHA Library, Federico Zingarelli, 419904

THE ROLE OF ALLO-HSCT IN AML CR1 PATIENTS WITH MRD NEGATIVITY AFTER THE FIRST INDUCTION COURSE

EHA Library, Elena Parovichnikova, 419905

DECITABINE PRIMING WITH CYTARABINE FOLLOWED BY UCB INFUSION AFTER VA THERAPY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA : A SINGLE-CENTRE RETROSPECTIVE ANALYSIS

EHA Library, Li Ye, 419906

A MAXIMUM SINGLE DOSE OF ALLOGENEIC CAR-NK INFUSION IN AN ACUTE MYELOCYTIC LEUKEMIA PATIENT

EHA Library, Li Zhou, 419907

OUTCOMES AMONG NON-WESTERN IMMIGRANT PATIENTS AND DANISH-BORN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A DANISH POPULATION-BASED COHORT STUDY

EHA Library, Daniel Tuyet Kristensen, 419908

ADVANCING THE UNDERSTANDING OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) THROUGH INTERNATIONAL COLLABORATION: ANALYSIS OF 62 PATIENTS’ DATA FROM THE BPDCN GLOBAL REGISTRY

EHA Library, Astghik Voskanyan, 419909

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CYTARABINE IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED AML: PHARMACOKINETICS, SAFETY AND EFFICACY

EHA Library, Wenyu Yang, 419910

IMPROVED CARE-PATHWAY CAN INCREASE THE OVERALL SURVIVAL AMONG ACUTE MYELOID LEUKAEMIA PATIENTS: A POPULATION-BASES STUDY USING DOUBLY ROBUST CAUSAL INFERENCE METHODS.

EHA Library, Kueshivi Midodji ATSOU, 419911

VALIDATION OF OPTICAL GENOME MAPPING AS A POTENTIAL STANDARD OF CARE CYTOGENOMIC METHODOLOGY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Joanna Kamaso, 419912

PLCG2 Δ20-22 EXON-SKIPPED VARIANTS IN PRIMARY CLL

EHA Library, Jialei Qi, 419913

CODING AND REGULATORY REGIONS AFFECTED BY 17P AND 11Q DELETIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Romana Nesnadná, 419914

GENE POLYMORPHISM AND PRIMARY MULTIPLE METACHRONIC TUMORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA

EHA Library, Elena Nazarova, 419915

CYTOGENOMIC RESPONSE EVOLUTION IN TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS USING OPTICAL GENOME MAPPING AND NEXT-GENERATION SEQUENCING

EHA Library, Rocío García-Serra, 419916

CHARACTERIZATION OF CD38 EXPRESSION IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) PATIENTS: A SINGLE-CENTER EXPERIENCE OF 20 CASES

EHA Library, Giulia Calabretto, 419917

PREDICTING CLINICAL RESPONSE OF NON-HODGKIN LYMPHOMA WITH AN EX VIVO TUMOR MICROENVIRONMENT MODEL

EHA Library, Shazia Nakhoda, 419918

DISTINCT PATTERNS OF IN VIVO CLASS SWITCH RECOMBINATION EVENTS IN DIFFERENT IMMUNOGENETIC SUBGROUPS OF CLL: IMPLICATIONS FOR DISEASE ONTOGENY

EHA Library, Electra Sofou, 419919

OUTCOMES OF EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA TREATED WITH FIRST-LINE ACALABRUTINIB VIA THE UK EARLY ACCESS PROGRAMME; INTERIM ANALYSES.

EHA Library, Nicolas Martinez-Calle, 419920

PATIENT-REPORTED OUTCOME (PRO)–BASED RECURRENT SYMPTOMATIC DETERIORATION PREDICTS DISEASE PROGRESSION: RESULTS FROM THE ALPINE TRIAL

EHA Library, Jennifer R. Brown, 419921

CROSS-STUDY COMPARISON OF IBRUTINIB PLUS VENETOCLAX (I+V) VS VENETOCLAX PLUS OBINUTUZUMAB (V+G) IN SUBJECTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH COMORBIDITIES

EHA Library, Francisco Javier Lopez Jimenez, 419922

RISK OF HYPERTENSION IN PATIENTS WITH CLL/SLL WHO PARTICIPATED IN ALPINE: A POST HOC ANALYSIS

EHA Library, William B. White, 419923

POSTINFUSION RESOURCE USE AND COST OF LISOCABTAGENE MARALEUCEL BY RESPONSE STATUS AND PRIOR LINES OF THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA FROM TRANSCEND CLL 004

EHA Library, November McGarvey, 419924

IMPACT OF IGHV SUBSETS ON THE ROBUSTNESS OF DIFFERENT RISK SCORES TO PREDICT CLL PROGRESSION

EHA Library, Miguel Argüello de Tomás, 419925

UPDATED RESULTS OF COMBINATION TREATMENT WITH IBRUTINIB AND VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND COMPLEX KARYOTYPE: 4-YEAR FOLLOW-UP

EHA Library, Maria Kislova, 419926

RISK ADAPTED MANAGEMENT OF PATIENTS WITH EARLY-STAGE ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA USING ACALABRUTINIB WITH OR WITHOUT OBINUTUZUMAB

EHA Library, Sameer Parikh, 419927